Source: LibraryDue February 5, 2026
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
by HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Deadline
February 5, 2026
Award Amount
Varies
Eligibility
No Set aside used. NONE
About this opportunity
Full details for this opportunity are available on the official funder website. View the official posting for complete information about eligibility, requirements, and how to apply.
Verified Information
- Deadline confirmed
- Secure connection